The use of patient-controlled epidural analgesia (PCEA) for labour analgesia is rapidly gaining acceptance. However, the ideal PCEA solution and PCEA program remains uncertain. We studied the effect of adding fentanyl 2 µg/ml on demand-only PCEA using ropivacaine 0.125% for labour analgesia.
Ropivacaine is emerging as an important local anaesthetic in the field of obstetric analgesia, due to lower cardiotoxicity than alternatives and alleged better differential sensory and motor blockade.
The use of patient-controlled epidural analgesia (PCEA), particularly with demand-only mode, reduces the local anaesthetic requirement for labour pain relief [1] [2] [3] [4] [5] [6] [7] . In a previous study in our institution, we have shown that the use of demand-only patientcontrolled epidural analgesia with ropivacaine 0.2% reduced the incidence of motor blockade when compared to a continuous infusion 8 . However, the optimal solution for patient-controlled epidural analgesia in labour remains uncertain.
The addition of opioids to local anaesthetics in continuous infusions has been shown to reduce the local anaesthetic requirement, without compromising labour analgesia. This, in turn, has reduced the degree of motor blockade 9, 10 . In this study, we assessed the dose-sparing effect of adding fentanyl 2 µg/ml to ropivacaine 0.125% using demand-only patient-controlled epidural analgesia for labour pain relief.
MATERIALS AND METHODS
We conducted a prospective, randomized, doubleblind study after receiving approval from the Hospital Ethics Committee. Thirty-six term nulliparous parturients who were below 45 years of age and weighed less than 100 kg were recruited into the study. All were ASA 1 and 2 and were in established labour (spontaneous or augmented) with a cervical dilatation not more than 5 cm. Those with obstetric complications (e.g., non-vertex presentation, multiple pregnancy, previous caesarean delivery, prematurity), those who had a contraindication to regional anaesthetic, and those with allergies to opioid or local anaesthetics were excluded from the study. Parturients who received prior opioid analgesia during labour or who did not understand the use of patient-controlled analgesia were also excluded.
After obtaining written informed consent, epidural analgesia was initiated. The parturients were first preloaded intravenously with 0.5 litres of crystalloid. Baseline heart rate and non-invasive blood pressure (taken on the left arm at the level of the heart with the patient in left lateral tilt) were recorded. A preepidural pain score was obtained using a visual analog scale (VAS) from 0 to 100 (0=no pain and 100=worst pain imaginable).
The epidural catheter was then inserted in the right lateral position at the L2/3 or L3/4 interspace using the midline approach. A loss-of-resistance-to-air technique with a 17 gauge Tuohy needle was used to identify the epidural space and a 19 gauge catheter was inserted 3 to 4 cm into the epidural space. After negative aspiration to blood and cerebrospinal fluid, a test dose of 3 ml of 1.5% lignocaine was given. Subsequently, upon satisfactory placement of the catheter, a bolus of 10 ml of 0.2% ropivacaine was administered in 3 to 4 ml aliquots. The patients were then placed in left lateral tilt.
During the first 30 minutes after the initial bolus, the patients' blood pressure and heart rate were taken every five minutes. Patients who developed hypotension (defined as a 20% reduction in baseline systolic blood pressure) were treated with further intravenous fluid loading and/or boluses of ephedrine 6 mg. The pain scores (VAS) and the highest sensory level to cold (ice) were measured every 15 minutes. Patients who had inadequate pain relief (defined as VAS >30) 15 minutes after the initial bolus were given an additional 5 ml bolus of ropivacaine 0.2%. Only patients with adequate pain relief (defined as VAS 30) 30 minutes after the initial bolus were included in the study. This was done to ensure appropriate catheter placement and uniform sensory blockade before initiating the PCEA program. VAS >30 was taken as the cut-off because it has been shown to correspond to adequate patient comfort 11 .
The parturients were then started on the PCEA program using the Graseby 9300 PCA pump. They were randomized into two groups to receive either:
Group RF (study group): ropivacaine 0.125% with fentanyl 2 µg/ml Group R (control group): ropivacaine 0.125%.
The PCEA was programmed in the demand-only mode with no baseline infusion. Each demand delivered 5 ml of solution with a lockout interval of 10 minutes and a maximum of 20 ml/h. The women were instructed to activate the demand button as soon as they began to feel pain and were advised to allow a few minutes for each demand to take effect. They were reassured of the safety of the technique and that they would be regularly monitored.
Throughout the study, the patients were monitored using continuous fetal cardiotocography. The fetal cardiotocograms (CTGs) were confirmed to be reactive prior to the labour analgesia. Blood pressure and heart rate were taken every 15 minutes. An anaesthetist reviewed the parturients every two hours with regard to: 1. blood pressure and heart rate, 2. pain scores (VAS), 3. bilateral sensory level to cold (ice), 4. modified Bromage score, where 0=no motor blockade of both lower limbs, 1=unable to perform straight-leg raising of either leg but able to bend the knee and ankle, 2=unable to perform straight-leg raising or flex the knee but able to flex the ankle, 3=not able to do either of the above, 5. sedation score, where 0=awake and alert, 1= occasionally drowsy but easy to arouse, 2=frequently drowsy and easy to arouse, 3=difficult to arouse, S=sleeping and easy to arouse, 6. ratio of successful PCEA demand to total number of demands, 7. volume and amount of ropivacaine used.
Data on the demographic profile of the patient, side-effects (e.g., hypotension, nausea and vomiting, pruritus, shivering and sedation), obstetric outcome (e.g., duration of labour, duration of second stage and mode of delivery), neonatal outcome (Apgar score and birthweight) were collected. Overall patient satisfaction scores for epidural analgesia were obtained within two hours of delivery, using a VAS (0=poor and 100=excellent).
During the period of the study, rescue medications consisting of 5 ml aliquots of ropivacaine 0.2% were available if the VAS exceeded 30 or if the woman complained of pain at any time. The study was terminated at spontaneous vaginal delivery or when an obstetric decision was made to intervene and effect delivery.
For the analysis of data, parturients who had used the PCEA for less than two hours were excluded 5,6 . Parturients who had sensory block higher than T4 were withdrawn from the study to exclude possible intrathecal or subdural catheter placement. In the analysis of the data, the initial bolus of 10 ml of ropivacaine 0.2% was not included in the calculation of the cumulative ropivacaine used by the patient, as doing so would inflate the ropivacaine requirement, especially in short labours [1] [2] [3] 12 . The parametric demographic data such as age, height and weight were analysed using the unpaired Student's t-test. The
Mann-Whitney U test was used for comparison of VAS pain scores, highest sensory level to cold, amount of ropivacaine used, ratio of PCEA demands and parturients' overall satisfaction scores. Fisher's exact test was used for comparisons of proportion. Statistical significance was taken as P<0.05. The sample size was computed to detect a 25% reduction in amount of ropivacaine used per hour in the study group with a power of 0.8 and α <0.05.
RESULTS
In total, four parturients were removed from the study because they had used the PCEA for less than two hours. The demographic profile of both groups was similar. The initial cervical dilatation and the proportion of parturients having induction or augmentation of labour were also not significantly different ( Table 1 ).
The baseline VAS pain scores and the pain scores 30 minutes after the initiation of epidural (i.e., at the beginning of the PCEA program), were not significantly different. This represented a similar reduction in pain scores from the initial bolus before the initiation of the PCEA program ( Table 2 ). The median VAS pain scores at 2, 4, 6 and 8 hours during first stage of labour were similar (Figure 1 ).
The amount of ropivacaine used per hour was significantly lower in the RF group compared with group R (P=0.03) ( Table 3 ). There was no significant difference in the percentage of successful demands to total number of demands. There was one patient in each group who required physician-administered rescue boluses in the first stage of labour (Table 3) . Three patients in group R and two patients in group RF required additional analgesia during the second stage of labour. The highest sensory level to cold was similar. Values are mean (SD) except initial cervical dilatation expressed as median (range) and oxytoxic use as proportion. --R 0.125% + F 2mg/ml --R 0.125% There was no difference between the two groups with respect to hypotension, nausea and vomiting, sedation, pruritus or shivering ( Table 4 ). The incidence of motor block (modified Bromage score >0) was also not significantly different between the two groups. Of note, the majority of the motor block occurred at the initiation of the epidural and none of the patients had a Bromage score of greater than one ( Table 5 ).
The duration of first stage of labour after the establishment of the epidural, the duration of the second stage and the mode of delivery were also similar ( Table 6 ). The neonatal outcome and birthweight were not statistically different between the two groups ( Table 7) . Patients' satisfaction scores were very high ( Table 2) but not significantly different.
DISCUSSION
The addition of fentanyl 2 µg/ml to ropivacaine 0.125% in a demand-only PCEA program produced a 30% reduction in the amount of ropivacaine required to achieve a similar analgesic level (Table 3 ). This is in keeping with previous studies that have shown a dosesparing effect of an opioid on dilute bupivacaine solutions, administered either as a continuous infusion or as a PCEA solution 9, [12] [13] [14] [15] [16] . However, in this study this reduction in the amount of ropivacaine delivered did not result in a clinically significant reduction in motor block, nor affect the mode of delivery. Parturient satisfaction scores were high in both groups, despite a reduction in the amount of ropivacaine required with the addition of fentanyl. There is a synergistic action of fentanyl and ropivacaine at the dorsal horn of the spinal cord and combinations of opioid and local anaesthetic produce effective labour analgesia 12, [15] [16] [17] .
It has been suggested that the slow onset of analgesia after a bolus of PCEA analgesic solution may lead to an inappropriate increase in patient demands during the PCEA lockout period, resulting in a poorer percentage of successful demands 12 . Previous studies have postulated that the addition of fentanyl may hasten the onset of analgesia of the PCEA bolus, thereby improving the percentage of successful demands 12, 15, 16 . We found no difference between groups in the percentage of successful demands. It may be that the addition of higher concentrations of fentanyl or a more rapidly acting opioid may further hasten the onset of analgesic boluses, thereby achieving a greater percentage of successful demands 9, 18 .
The addition of fentanyl 2 µg/ml to ropivacaine 520 P. RUBAN, A. All values are number. 0.125% provided excellent labour analgesia and resulted in no significant difference in side-effects, minimal motor blockade, similar neonatal outcome and similar mode of delivery. The incidence of motor blockade was low in both groups, with the modified Bromage score never exceeding one. Although it has been reported that the incidence of shivering after epidural may be reduced with the use of opioids, this was not demonstrated in this study 5, 19 . The use of PCEA in labour analgesia provides excellent patient satisfaction as it allows patients to tailor their individual analgesic requirement t2,7 . The ability to be in control adds to patient satisfaction. As is shown in this study, PCEA allows self-titration to achieve similar analgesic efficacy in labour, despite a difference in analgesic solution 20 .
We found the demand-only mode of PCEA, without a baseline infusion, achieved good analgesia and high patient satisfaction. This supports the notion that a continuous background infusion may not be essential to achieve good analgesia in PCEA 2,6 . Nevertheless, the role of a background infusion remains unclear and further research is required in this aspect.
In conclusion, the addition of fentanyl 2 µg/ml to ropivacaine 0.125% produced a dose-sparing effect with respect to the amount of ropivacaine required to produce good labour analgesia. However, this reduction in ropivacaine dosage did not influence the degree of motor block or mode of delivery. It is possible larger studies with adequate power or the use of higher opioid concentrations or more potent opioids as adjuncts may result in a difference. Nevertheless, demand-only PCEA with both solutions provided excellent labour pain relief with minimal side-effects.
